The American Journal of Surgery
Volume 194, Issue 4 , Pages 474-476 , October 2007

Primary breast tumor characteristics predicting aggressive nodal involvement

Presented at the 8th Annual Meeting of the American Society of Breast Surgeons, Phoenix, AZ, May 2–6, 2007

Received 1 May 2007 ,Revised 26 June 2007

References 

  1. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45:2917–2924
  2. Wilson RE, Donegan WL, Mettlin C, et al. The 1982 survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet. 1984;159:309–319
  3. Allan AL, George R, Vantyghem SA, et al. Role of the integrin-binding protein osteopontin in lymphatic metastatis of breast cancer. Am J Pathol. 2006;169:233–246
  4. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A noval human xenograft model of inflammatory breast cancer. Cancer Res. 1999;59:5079–5084
  5. Roberts N, Kloos B, Cassella M, et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 2006;66:2650–2657
  6. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61:5231–5241
  7. Tsuchiya A, Kanno M, Abe R. The impact of lymph node metastases on the survival of breast cancer patients with ten or more positive lymph nodes. Jpn J Surg. 1997;27:902–906
  8. Jones SE, Moon TE, Bonadonna G, et al. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol. 1987;10:387–395

PII: S0002-9610(07)00534-X

doi: 10.1016/j.amjsurg.2007.06.009

The American Journal of Surgery
Volume 194, Issue 4 , Pages 474-476 , October 2007

Article Tools

* Image Usage & Resolution